Trend Signal Now: The Hot Corner: RA Capital Reports a $25.3 Million JANX Purchase

Monday, March 10, 2025

📌 The most significant insider transaction comes from RA Capital Healthcare Fund, which made a massive $25.3 million purchase of Janux Therapeutics $JANX shares.

Given RA Capital's expertise in biotech, this is a notable show of confidence in the company's future.

📌 CFO Jonathan Halkyard of MGM Resorts International $MGM filed a Form 4 revealing the purchase of 10,000 shares.

This is a move worth watching, as CFOs typically only buy when they see strong upside potential.

Here's The Hot Corner, with data from March 7, 2025:

Click the table to enlarge it.

📌 Cathie Wood's ARK Investment Management increased its stakes in both PagerDuty $PD and Twist Bioscience $TWST, raising its position in PD from 9.98% to 10.35% and in TWST from 9.39% to 10.70%.

📌 And Rep. Josh Gottheimer of New Jersey reported buying $1 million to $5 million worth of Microsoft $MSFT stock.

Are You Multiplying Your Breakouts?

It is messy out there, but it is also still a bull market.

And we're multiplying more breakouts than ever right now.

The Hot Corner Insider

Here's what's happening with The Hot Corner Insider:

We get together on Wednesdays for the Hot Corner Insider Weekly Strategy Session. And we compile the recordings from each and every one in the Strategy Session Archive.

Note that all actionable setups we discuss in The Hot Corner Insider are compiled on the Trade Ideas page.

And please reach out if you have any questions.

Alfonso Depablos | Senior Analyst, All Star Charts

Stock Market Media emails are a financial publication of general circulation and only offers impersonal advice, not tailored to individual needs of a specific client or group. Any comments or statements made herein do not necessarily reflect those of Stock Market Media LLC or its affiliates (collectively, "Stock Market Media") and do not constitute buy or sell recommendations. Unless specifically indicated, this message is not an official confirmation of any transaction. The contents of any email communications to or from Stock Market Media may be monitored or reviewed at Stock Market Media's discretion. Stock Market Media accepts no responsibility for any loss or damage arising in any way from the use of this transmission and any attachments; it is the responsibility of the recipient to ensure that they are virus free. If you reply to this email, please note that we are a public investor and do not want any material non-public information. We do not agree to keep confidential any information you provide and do not agree to any restrictions on our trading activity, except pursuant to a written confidentiality agreement executed by Stock Market Media.

Want to change how you receive these emails? You can manage your preferences here

unsubscribe